Talk:Palmitoylethanolamide

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

This article was created or improved during WikiProject Cannabis' "420 Collaboration" in 2023.

External links in article body

These links are not allowed, and I am removing them from the article body ("Clinical relevance" section). They are posted below, followed by the relevant phrase, if somebody would like to either turn them into refs or else add them to an External Links section:

https://www.dovepress.com/palmitoylethanolamide-a-neutraceutical-in-nerve-compression-syndromes--peer-reviewed-article-JPR "In a 2015 analysis of a double blind placebo controlled study of PEA in sciatic pain, the Numbers Needed to Treat was 1.5."

http://www.hindawi.com/journals/iji/2013/151028/ "In 2013 a review was published on the clinical efficacy and safety of PEA in flu,"

http://www.hindawi.com/journals/joph/2015/430596/ "These effects are also the explanation of PEA's retinoprotectant effects." --Quisqualis (talk) 06:46, 28 January 2017 (UTC)[reply]

LifeExtension magazine, March 2019

Wikipedia says: "PEA also seems to be one of the factors responsible for the decrease in pain sensitivity during and after sport, comparable to the endogenous opiates (endorphines)".

Could PEA be replaced by daily sports?

What could be the theoretical adverse effects?

LifeExtension magazine, March 2019 wrote about PEA:

March 2019: https://www.lifeextension.com/Magazine/2019/3/Turn-off-the-Pain-Signal/Page-01

SS 2017: https://www.lifeextension.com/Magazine/2017/SS/Break-the-Cycle-of-Chronic-Pain/Page-01

https://www.lifeextension.com/Search#q=palmitoylethanolamide&sort=relevancy&f:hierarchicalcategory=[Magazines]

Most of the clinical studies they refer to are all small, with small amount of participants or short duration.

LifeExtension magazine promotes dietary supplements (lots of tablets, instead of for example just doing daily sports), so it is a bit biased source of information.

I found almost nothing about PEA at Consumerlab.com and examine.com websites:

https://www.consumerlab.com/search/palmitoylethanolamide-review/

--ee1518 (talk) 12:30, 18 March 2019 (UTC)[reply]

What's your point? Are you suggesting we incorporate that website's material into the article, or not? So far, it seems clean of LE citations.--Quisqualis (talk) 15:30, 18 March 2019 (UTC)[reply]

Please cease with WP:VER and WP:OR violations

These Wikipedia guidelines call for reportable information to be drawn from the review and other secondary and tertiary literatures, and not from our own insights, or from the morass of primary sources that wander about biological, chemical, and physical realities before they settle, eventually, through the secondary literatures, on what might be considered "true" about the scientific subject.

In order to be accurate here, work from secondary sources, supporting them from the primary. Occasionally, absent good review content, we can sample the "minireview" content of the introduction and discussion sections of primary reports, until the authoritative reviews are written, but only if these primary reports are from good labs, in good journals. Even when purely focused on the secondary and tertiary literatures, we need to be aware of secondary source shortcomings—e.g., when most reviews are by the same person/team, when the reviews are in poor journals, when the reviews are overly positivistic as authors promotionally self-serve their own research area. After that—after summarizing the review literature—we stop talking. We absolutely do not don't fill in the gaps from our own perceptions, or inferences. That is WP:OR, and is forbidden here. We speak when the authorities speak, and if not from them, not at all.

Right now the article is headed toward mediocrity or irrelevance, because a pattern has been established of making arguments from this labile, inconstant primary report morass—worse, creating the expectation that others will selectively add review citation support after the fact, which makes for a real mess. (A mess because only a true, narrow subject matter expert can then sort which primary source reports have prevailed, versus gone by the wayside. And when there are some 60 of them, such winnowing essentially never happens.) So, after today, I will tag original remarks with ^{[citation needed]} or ^{[original research?]} template messages (or remove them if they are speculative), and will begin to call attention to all statements only supported by primary sources. Cheers, a relative expert, and former logging WP editor. 12.205.207.2 (talk) 20:13, 26 February 2020 (UTC)[reply]

Goodbye wikipedia

Peer reviewed scientific studies aren't enough and secondary sources are needed? That's a pretty stupid and rather arbitrary standard. Secondary sources? Screw you wikipedia. How about dismissing Wikipedia altogether for nt having enough "secondary sources"? Cuvtixo (talk) 19:56, 6 February 2021 (UTC)[reply]

Hello, can somebody help and add this information to this page?

Due to my careless action of leaving a VPN on while going to make an edit, I'm unable to make any edits at the moment and add any more to this page for a few more months. Can someone include this information when they next make an edit?

A review with further information explaining the interest from the pharma industry in PEA for inflammation caused by SARS-CoV-2 infections - https://onlinelibrary.wiley.com/doi/10.1002/ptr.6978 - Phytotherapics in COVID19: Why palmitoylethanolamide? (2020)

For tidying up the early studies section, these two papers have a lot of the missing citations necessary for covering the timeline for isolation, discovery, and further research into its pleiotropic mechanisms of action.

https://www.academia.edu/28829666/Palmitoylethanolamide_Research_Synergy_between_Academia_and_Industry_Based_on_Insights_and_Work_of_Nobel_Laureate_Rita_Levi_Montalcini?email_work_card=title - Palmitoylethanolamide: Research Synergy between Academia and Industry, Based on Insights and Work of Nobel Laureate Rita Levi-Montalcini (2005)

https://www.academia.edu/3089172/The_search_for_the_palmitoylethanolamide_receptor - The search for the palmitoylethanolamide receptor (2005)

Foshaw (talk) 19:17, 8 March 2021 (UTC)[reply]